300791 仙乐健康
已收盘 02-06 15:00:00
资讯
新帖
简况
仙乐健康(300791)披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告,2月5日股价上涨0.5%
证券之星 · 02-05 22:36
仙乐健康(300791)披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告,2月5日股价上涨0.5%
业绩增速放缓 仙乐健康赴港筹钱
北京商报 · 02-05
业绩增速放缓 仙乐健康赴港筹钱
锚定全球化 仙乐健康冲刺“A+H”上市
经济参考报 · 02-04
锚定全球化 仙乐健康冲刺“A+H”上市
仙乐健康冲刺港股:预计年净利1亿到1.5亿 降幅超50%
雷递网 · 02-02
仙乐健康冲刺港股:预计年净利1亿到1.5亿 降幅超50%
新股前瞻|从业绩“深蹲”到全球跃迁:解码仙乐健康(300791.SZ)的破局逻辑
智通财经网 · 01-31
新股前瞻|从业绩“深蹲”到全球跃迁:解码仙乐健康(300791.SZ)的破局逻辑
新股消息 | 仙乐健康(300791.SZ)递表港交所
智通财经 · 01-30
新股消息 | 仙乐健康(300791.SZ)递表港交所
仙乐健康最新公告:2025年净利同比预降53%-69%
中金财经 · 01-29
仙乐健康最新公告:2025年净利同比预降53%-69%
仙乐健康(300791)披露2026年第一次临时股东大会决议公告,1月27日股价下跌2.51%
证券之星 · 01-27
仙乐健康(300791)披露2026年第一次临时股东大会决议公告,1月27日股价下跌2.51%
股市必读:仙乐健康(300791)1月23日董秘有最新回复
证券之星 · 01-26
股市必读:仙乐健康(300791)1月23日董秘有最新回复
仙乐健康加码全球化布局,拟赴港上市并剥离亏损子公司
新京报 · 01-12
仙乐健康加码全球化布局,拟赴港上市并剥离亏损子公司
国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康谋港股上市
蓝鲸财经 · 01-12
国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康谋港股上市
仙乐健康最新公告:拟发行H股股票并在香港联交所主板上市
证券之星 · 01-11
仙乐健康最新公告:拟发行H股股票并在香港联交所主板上市
仙乐健康(300791)披露2025年第四季度取得发明专利证书和保健食品注册证书、备案凭证,1月6日股价下跌0.78%
证券之星 · 01-06
仙乐健康(300791)披露2025年第四季度取得发明专利证书和保健食品注册证书、备案凭证,1月6日股价下跌0.78%
仙乐健康(300791)披露2025年第四季度可转债转股情况,1月5日股价下跌1.47%
证券之星 · 01-05
仙乐健康(300791)披露2025年第四季度可转债转股情况,1月5日股价下跌1.47%
股市必读:仙乐健康(300791)12月23日董秘有最新回复
证券之星 · 2025-12-24
股市必读:仙乐健康(300791)12月23日董秘有最新回复
仙乐健康:积极推进Best Formulations PC LLC剥离出售
证券之星 · 2025-12-23
仙乐健康:积极推进Best Formulations PC LLC剥离出售
仙乐健康(300791)披露2025年限制性股票激励计划预留授予部分完成登记,12月05日股价下跌0.26%
证券之星 · 2025-12-05
仙乐健康(300791)披露2025年限制性股票激励计划预留授予部分完成登记,12月05日股价下跌0.26%
仙乐健康(300791)9月30日股东户数1.18万户,较上期减少2.97%
证券之星 · 2025-10-28
仙乐健康(300791)9月30日股东户数1.18万户,较上期减少2.97%
仙乐健康(300791.SZ)发布前三季度业绩,归母净利润2.6亿元,增长8.53%
智通财经 · 2025-10-28
仙乐健康(300791.SZ)发布前三季度业绩,归母净利润2.6亿元,增长8.53%
股市必读:仙乐健康(300791)10月23日董秘有最新回复
证券之星 · 2025-10-24
股市必读:仙乐健康(300791)10月23日董秘有最新回复
加载更多
公司概况
公司名称:
仙乐健康科技股份有限公司
所属行业:
食品制造业
上市日期:
2019-09-25
主营业务:
仙乐健康科技股份有限公司的主营业务是为全球营养健康食品行业的客户提供包括基础研究与产品开发、制造、包装、物流及市场营销支持在内的全链式解决方案。公司的主要产品是软胶囊、营养软糖、饮品、片剂、粉剂、硬胶囊、素怡Plantegrity植物基软胶囊、萃优酪凝胶软片、爆珠、维浆果肠衣软糖、益生菌晶球、乳态饮。近三年,公司参与中国食品安全国家标准起草修订8项,行业标准起草制定4项,团体标准起草制定9项;美国药典(USP)标准制定5项;其中已有13项标准正式发布。
发行价格:
54.73
{"stockData":{"symbol":"300791","market":"SZ","secType":"STK","nameCN":"仙乐健康","latestPrice":21.86,"timestamp":1770361389000,"preClose":21.98,"halted":0,"volume":3420274,"delay":0,"changeRate":-0.0055,"floatShares":256999999,"shares":308000000,"eps":1.1232,"marketStatus":"已收盘","change":-0.12,"latestTime":"02-06 15:00:00","open":21.97,"high":22.1,"low":21.83,"amount":74970900,"amplitude":0.0123,"askPrice":21.86,"askSize":110,"bidPrice":21.85,"bidSize":269,"shortable":0,"etf":0,"ttmEps":1.1232,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":21.98,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":24.18,"lowLimit":19.78,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":307634663,"isCdr":false,"pbRate":2.76,"roa":"--","peRate":19.462251,"roe":"10.07%","epsLYR":1.3916,"committee":0.3217,"marketValue":6725000000,"turnoverRate":0.0133,"status":1,"floatMarketCap":5608000000},"requestUrl":"/m/hq/s/300791","defaultTab":"news","newsList":[{"id":"2609301359","title":"仙乐健康(300791)披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告,2月5日股价上涨0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609301359","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609301359?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:36","pubTimestamp":1770302180,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,仙乐健康报收于21.98元,较前一交易日上涨0.5%,最新总市值为67.62亿元。该股当日开盘21.77元,最高22.27元,最低21.73元,成交额达7996.23万元,换手率为1.41%。公告显示,公司对2026年限制性股票激励计划内幕信息知情人在自查期间买卖公司股票情况进行了自查。公司未发现内幕信息知情人泄露或利用内幕信息买卖股票的情况,相关行为符合监管规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2609311793","title":"业绩增速放缓 仙乐健康赴港筹钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2609311793","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609311793?lang=zh_cn&edition=full","pubTime":"2026-02-05 00:14","pubTimestamp":1770221640,"startTime":"0","endTime":"0","summary":"近日,营养健康食品解决方案提供商仙乐健康正式向港交所主板递交上市申请,拟构建“A+H”双资本平台。仙乐健康是国内大型营养健康食品合同生产(CDMO)企业之一。结合近三年业绩表现,仙乐 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260205/c674561292.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260205/c674561292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2608812493","title":"锚定全球化 仙乐健康冲刺“A+H”上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2608812493","media":"经济参考报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608812493?lang=zh_cn&edition=full","pubTime":"2026-02-04 07:51","pubTimestamp":1770162660,"startTime":"0","endTime":"0","summary":"日前,仙乐健康科技股份有限公司(简称“仙乐健康”,300791.SZ)发布公告,已正式向香港联交所递交主板上市申请。此次赴港上市,旨在深化公司全球化战略布局,打造多元化资本运作平台,增 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20260204/c674530739.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20260204/c674530739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2608868190","title":"仙乐健康冲刺港股:预计年净利1亿到1.5亿 降幅超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608868190","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608868190?lang=zh_cn&edition=full","pubTime":"2026-02-02 18:38","pubTimestamp":1770028681,"startTime":"0","endTime":"0","summary":"仙乐健康科技股份有限公司(简称:“仙乐健康”)日前递交招股书,准备在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260202/6390565427120128081529139.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260202/6390565427120128081529139.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32548/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["300791","BK4585","BK0226","BK4588","VT"],"gpt_icon":0},{"id":"2607893076","title":"新股前瞻|从业绩“深蹲”到全球跃迁:解码仙乐健康(300791.SZ)的破局逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2607893076","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607893076?lang=zh_cn&edition=full","pubTime":"2026-01-31 14:11","pubTimestamp":1769839904,"startTime":"0","endTime":"0","summary":"作为营养健康食品解决方案行业的全球前三、中国第一的头部企业,仙乐健康在2026年初的一系列动作,无疑为这个转型期的行业投下了一枚重磅炸弹。值得关注的是,仙乐健康期间费用率显著上升。同期行政费用为35.56亿元,费用率10.81%,较2024年同期的9.79%上升1.02个百分点。从中国龙头到全球领袖的跨越路径全球营养健康食品解决方案行业正处于量价齐升的黄金发展期。2025年第三季度数据显示,仙乐健康中国区转型已进入收获期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2607052040","title":"新股消息 | 仙乐健康(300791.SZ)递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2607052040","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607052040?lang=zh_cn&edition=full","pubTime":"2026-01-30 06:45","pubTimestamp":1769726703,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据港交所1月29日披露,仙乐健康科技股份有限公司向港交所主板递交上市申请书,中信证券为其独家保荐人。该公司是领先的营养健康食品解决方案提供商,根据灼识咨询数据按2024年的收入计,该公司于全球营养健康食品解决方案市场占据第三大市场份额,而在中国营养健康食品解决方案市场则排名第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HEXmain","BK0226","300791"],"gpt_icon":0},{"id":"2607820110","title":"仙乐健康最新公告:2025年净利同比预降53%-69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607820110","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607820110?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:49","pubTimestamp":1769690960,"startTime":"0","endTime":"0","summary":"仙乐健康(300791.SZ)公告称,仙乐健康预计2025年归属于上市公司股东的净利润为1.01亿元–1.51亿元,比上年同期下降53%–69%。业绩变动主要系个人护理业务经营环境恶化、客户需求下降、中美贸易摩擦推高成本,叠加团队变动致该板块全年亏损增加;公司计提相关资产减值损失1.95亿元;同时发生较高战略咨询费用及精准营养、宠物营养等新赛道前期投入。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260129/31983798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2606738974","title":"仙乐健康(300791)披露2026年第一次临时股东大会决议公告,1月27日股价下跌2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606738974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606738974?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:41","pubTimestamp":1769524875,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘,仙乐健康报收于24.48元,较前一交易日下跌2.51%,最新总市值为75.31亿元。该股当日开盘25.09元,最高25.09元,最低24.18元,成交额达8021.39万元,换手率为1.28%。仙乐健康于2026年1月27日发布《2026年第一次临时股东大会决议公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700042154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2606265327","title":"股市必读:仙乐健康(300791)1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265327","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265327?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:01","pubTimestamp":1769367674,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,仙乐健康报收于24.96元,上涨0.08%,换手率0.93%,成交量2.39万手,成交额5938.13万元。董秘最新回复投资者: 董秘您好,据传贵司旗下Best Formulations美国工厂正在为圣元环保旗下圣元药业做进入美国市场的保健品?Best Formulations是公司的美国生产基地,致力于美国市场的开拓。当日关注点来自交易信息汇总:1月23日主力资金净流出386.15万元,显示主力短期看空情绪明显。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2602016512","title":"仙乐健康加码全球化布局,拟赴港上市并剥离亏损子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2602016512","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602016512?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:32","pubTimestamp":1768221120,"startTime":"0","endTime":"0","summary":"2023年1月,仙乐健康又收购了美国BFPC公司的控制权。截至2025年6月30日,仙乐健康商誉账面价值为4.35亿元,占公司报告期末归属于母公司的所有者权益比例为17.05%。国内业务收入下滑从经营业绩来看,2024年以来,仙乐健康境内业务经营承压,境外业务增速放缓。2024年,仙乐健康实现营业收入42.11亿元,同比增长17.56%;归属于上市公司股东的净利润3.25亿元,同比增长15.66%。","market":"sh","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl8820261121817112867093.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl8820261121817112867093.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1768221162168840.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1768221162168840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2602121115","title":"国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康国内市场增长乏力、信息化项目延期,保健品“隐形冠军”仙乐健康谋港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2602121115","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602121115?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:24","pubTimestamp":1768220658,"startTime":"0","endTime":"0","summary":"1月11日,仙乐健康发布公告称,公司拟发行H股并在香港联交所主板上市,德勤·关黄陈方会计师事务所担任本次审计机构。根据仙乐健康第四届董事会第十七次会议决议公告,本次H股发行方案已初步明确。尽管国内业务市场承压,但在仙乐健康关注的业务领域中,儿童营养软糖市场近年来热度较高。截至1月12日,仙乐健康的股价为24.75元人民币,总市值约为76.14亿元人民币。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1768220571308690551","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2602558269","title":"仙乐健康最新公告:拟发行H股股票并在香港联交所主板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2602558269","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602558269?lang=zh_cn&edition=full","pubTime":"2026-01-11 15:49","pubTimestamp":1768117770,"startTime":"0","endTime":"0","summary":"仙乐健康(300791.SZ)公告称,公司于2026年1月8日召开董事会,审议通过拟发行H股股票并在香港联交所主板上市的相关议案。公司旨在深化全球化战略布局,利用国际资本市场优势,打造多元化资本运作平台,进一步提高资本实力和综合竞争力,加快海外业务发展,完善境内外双循环格局。目前,公司正积极与相关中介机构就本次发行并上市的相关工作进行商讨,具体细节尚未最终确定。该事项存在较大不确定性,公司将及时履行信息披露义务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100002598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2601381328","title":"仙乐健康(300791)披露2025年第四季度取得发明专利证书和保健食品注册证书、备案凭证,1月6日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601381328","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601381328?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:27","pubTimestamp":1767709640,"startTime":"0","endTime":"0","summary":"公司近日发布公告称,仙乐健康科技股份有限公司在2025年第四季度取得9项发明专利证书,包括4项中国发明专利、2项欧洲发明专利、2项加拿大发明专利和1项澳大利亚发明专利,同时取得2项保健食品备案凭证,无新增保健食品注册证书。截至2025年12月31日,公司及子公司共拥有183项专利,其中发明专利107项;拥有108项保健食品注册证书和325项备案凭证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2601388838","title":"仙乐健康(300791)披露2025年第四季度可转债转股情况,1月5日股价下跌1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601388838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601388838?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:38","pubTimestamp":1767609511,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,仙乐健康报收于25.48元,较前一交易日下跌1.47%,最新总市值为78.39亿元。该股当日开盘25.86元,最高26.09元,最低25.06元,成交额达1.17亿元,换手率为1.8%。公司近日发布公告,披露2025年第四季度可转换公司债券转股情况。公告显示,2025年第四季度,“仙乐转债”因转股减少100元,合计转换为3股“仙乐健康”股票。截至2025年12月31日,公司剩余可转债为10,248,193张,票面总金额为1,024,819,300元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500029719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2593412285","title":"股市必读:仙乐健康(300791)12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412285?lang=zh_cn&edition=full","pubTime":"2025-12-24 02:06","pubTimestamp":1766513182,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘,仙乐健康报收于25.05元,下跌0.91%,换手率1.45%,成交量3.71万手,成交额9332.9万元。董秘最新回复投资者: 公司bf子公司剥离进度如何?公司正在积极推进控股子公司Best Formulations PC LLC的剥离/出售,公司将按照相关法律法规的规定及时履行信息披露义务。当日关注点来自交易信息汇总:12月23日主力资金净流出1533.15万元,散户资金净流入1727.54万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400000892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2593982794","title":"仙乐健康:积极推进Best Formulations PC LLC剥离出售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593982794","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593982794?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:39","pubTimestamp":1766479150,"startTime":"0","endTime":"0","summary":"证券之星消息,仙乐健康(300791)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:公司bf子公司剥离进度如何?仙乐健康回复:尊敬的投资者,您好!公司正在积极推进控股子公司Best Formulations PC LLC的剥离/出售,公司将按照相关法律法规的规定及时履行信息披露义务。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300024480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2589895803","title":"仙乐健康(300791)披露2025年限制性股票激励计划预留授予部分完成登记,12月05日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589895803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589895803?lang=zh_cn&edition=full","pubTime":"2025-12-05 17:49","pubTimestamp":1764928159,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘,仙乐健康报收于23.44元,较前一交易日下跌0.26%,最新总市值为72.04亿元。公司近日发布公告称,已完成2025年限制性股票激励计划预留授予部分限制性股票的授予登记工作。本次限制性股票授予日为2025年9月26日,上市日为2025年12月9日。实际授予限制性股票315,700股,占公司总股本的0.10%,授予价格为9.71元/股,共有20名激励对象获授。本次授予完成后,公司总股本增至307,634,660股,募集资金将用于补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500027866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0},{"id":"2578716939","title":"仙乐健康(300791)9月30日股东户数1.18万户,较上期减少2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578716939","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578716939?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:42","pubTimestamp":1761644568,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仙乐健康披露,截至2025年9月30日公司股东户数为1.18万户,较6月30日减少360.0户,减幅为2.97%。在食品加工行业个股中,仙乐健康股东户数低于行业平均水平,截至9月30日,食品加工行业平均股东户数为3.41万户。从股价来看,2025年6月30日至2025年9月30日,仙乐健康区间跌幅为0.13%,在此期间股东户数减少360.0户,减幅为2.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800032403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300791"],"gpt_icon":0},{"id":"2578980155","title":"仙乐健康(300791.SZ)发布前三季度业绩,归母净利润2.6亿元,增长8.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578980155","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578980155?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:13","pubTimestamp":1761639236,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙乐健康(300791.SZ)发布2025年三季度报告,该公司前三季度营业收入为32.91亿元,同比增长7.96%。归属于上市公司股东的净利润为2.6亿元,同比增长8.53%。归属于上市公司股东的扣除非经常性损益的净利润为2.44亿元,同比增长3.42%。基本每股收益为0.8523元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300791"],"gpt_icon":0},{"id":"2577310445","title":"股市必读:仙乐健康(300791)10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577310445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577310445?lang=zh_cn&edition=full","pubTime":"2025-10-24 05:00","pubTimestamp":1761253242,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘,仙乐健康报收于22.76元,上涨0.44%,换手率0.53%,成交量1.37万手,成交额3098.65万元。董秘最新回复投资者: 你好,请问公司是否有涉及人造肉领域?公司业务暂无涉及人造肉领域。当日关注点来自交易信息汇总:10月23日主力资金净流出206.67万元,散户资金净流入288.21万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400004247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300791","BK0226"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770493343361,"stockEarnings":[{"period":"1week","weight":-0.0658},{"period":"1month","weight":-0.1305},{"period":"3month","weight":-0.0956},{"period":"6month","weight":-0.0557},{"period":"1year","weight":0.1897},{"period":"ytd","weight":-0.1547}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仙乐健康科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"11761人(较上一季度减少2.97%)","perCapita":"21811股","listingDate":"2019-09-25","address":"广东省汕头市龙湖区泰山路83号","registeredCapital":"30763万元","survey":" 仙乐健康科技股份有限公司的主营业务是为全球营养健康食品行业的客户提供包括基础研究与产品开发、制造、包装、物流及市场营销支持在内的全链式解决方案。公司的主要产品是软胶囊、营养软糖、饮品、片剂、粉剂、硬胶囊、素怡Plantegrity植物基软胶囊、萃优酪凝胶软片、爆珠、维浆果肠衣软糖、益生菌晶球、乳态饮。近三年,公司参与中国食品安全国家标准起草修订8项,行业标准起草制定4项,团体标准起草制定9项;美国药典(USP)标准制定5项;其中已有13项标准正式发布。","listedPrice":54.73},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仙乐健康(300791)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仙乐健康(300791)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仙乐健康,300791,仙乐健康股票,仙乐健康股票老虎,仙乐健康股票老虎国际,仙乐健康行情,仙乐健康股票行情,仙乐健康股价,仙乐健康股市,仙乐健康股票价格,仙乐健康股票交易,仙乐健康股票购买,仙乐健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仙乐健康(300791)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仙乐健康(300791)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}